| 08:30 | 1901(W) | Anticoagulant and antiplatelet therapy in 20,442 patients with ischemic stroke and atrial fibrillation; results of an observational nationwide study | |
|
| 08:45 | 1902 | Clinical characterization of patients with acute first-ever ischemic stroke and atrial fibrillation by using the CHADS2 score: results from the German Ludwigshafen Stroke Study (LuSSt) | T Kleemann (Ludwigshafen, DE) |
|
|
Abstract
|
|
|
|
Slides
|
|
|
| 09:00 | 1903 | The HAS-BLED score also predicts cardiovascular events and mortality in atrial fibrillation | V Roldan-Schilling (Murcia, ES) |
|
|
|
Abstract
|
|
|
|
|
Slides
|
|
|
| 09:15 | 1904 | NT-proBNP for the detection of silent paroxysmal atrial fibrillation in patients with recent cerebral ischemia | R Wachter (Goettingen, DE) |
|
|
|
Abstract
|
|
|
|
|
Slides
|
|
|
| 09:30 | 1905 | Routine echocardiography to rule out paroxysmal atrial fibrillation in patients with cerebral ischemia presenting in sinus rhythm in the Find-AF trial | R Stahrenberg (Goettingen, DE) |
|
|
|
Abstract
|
|
|
|
|
Slides
|
|
|
| 09:45 | 1906 | May echocardiographic data improve CHADS2 risk score? | R A Providencia (Coimbra, PT) |
|
|
|
Abstract
|
|
|
|
|
Slides
|
|
|